185 related articles for article (PubMed ID: 26236485)
1. Pharmacological profiling of the hemodynamic effects of cannabinoid ligands: a combined in vitro and in vivo approach.
Walsh SK; Hepburn CY; Keown O; Åstrand A; Lindblom A; Ryberg E; Hjorth S; Leslie SJ; Greasley PJ; Wainwright CL
Pharmacol Res Perspect; 2015 Jun; 3(3):e00143. PubMed ID: 26236485
[TBL] [Abstract][Full Text] [Related]
2. Interacting binding insights and conformational consequences of the differential activity of cannabidiol with two endocannabinoid-activated G-protein-coupled receptors.
Dávila EM; Patricio F; Rebolledo-Bustillo M; Garcia-Gomez D; Hernandez JCG; Sanchez-Gaytan BL; Limón ID; Perez-Aguilar JM
Front Pharmacol; 2022; 13():945935. PubMed ID: 36016551
[TBL] [Abstract][Full Text] [Related]
3. A role for O-1602 and G protein-coupled receptor GPR55 in the control of colonic motility in mice.
Li K; Fichna J; Schicho R; Saur D; Bashashati M; Mackie K; Li Y; Zimmer A; Göke B; Sharkey KA; Storr M
Neuropharmacology; 2013 Aug; 71(100):255-63. PubMed ID: 23603203
[TBL] [Abstract][Full Text] [Related]
4. The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects.
Johns DG; Behm DJ; Walker DJ; Ao Z; Shapland EM; Daniels DA; Riddick M; Dowell S; Staton PC; Green P; Shabon U; Bao W; Aiyar N; Yue TL; Brown AJ; Morrison AD; Douglas SA
Br J Pharmacol; 2007 Nov; 152(5):825-31. PubMed ID: 17704827
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterization of GPR55, a putative cannabinoid receptor.
Sharir H; Abood ME
Pharmacol Ther; 2010 Jun; 126(3):301-13. PubMed ID: 20298715
[TBL] [Abstract][Full Text] [Related]
6. The orphan receptor GPR55 is a novel cannabinoid receptor.
Ryberg E; Larsson N; Sjögren S; Hjorth S; Hermansson NO; Leonova J; Elebring T; Nilsson K; Drmota T; Greasley PJ
Br J Pharmacol; 2007 Dec; 152(7):1092-101. PubMed ID: 17876302
[TBL] [Abstract][Full Text] [Related]
7. GPR55 and the vascular receptors for cannabinoids.
Hiley CR; Kaup SS
Br J Pharmacol; 2007 Nov; 152(5):559-61. PubMed ID: 17704825
[TBL] [Abstract][Full Text] [Related]
8. A novel CB receptor GPR55 and its ligands are involved in regulation of gut movement in rodents.
Lin XH; Yuece B; Li YY; Feng YJ; Feng JY; Yu LY; Li K; Li YN; Storr M
Neurogastroenterol Motil; 2011 Sep; 23(9):862-e342. PubMed ID: 21726355
[TBL] [Abstract][Full Text] [Related]
9. The cannabinoid ligands SR141716A and AM251 enhance human and mouse islet function via GPR55-independent signalling.
Ruz-Maldonado I; Liu B; Atanes P; Pingitore A; Huang GC; Choudhary P; Persaud SJ
Cell Mol Life Sci; 2020 Nov; 77(22):4709-4723. PubMed ID: 31925452
[TBL] [Abstract][Full Text] [Related]
10. GPR55: a new member of the cannabinoid receptor clan?
Pertwee RG
Br J Pharmacol; 2007 Dec; 152(7):984-6. PubMed ID: 17876300
[TBL] [Abstract][Full Text] [Related]
11. Cannabidiol reduced the striatal atrophy caused 3-nitropropionic acid in vivo by mechanisms independent of the activation of cannabinoid, vanilloid TRPV1 and adenosine A2A receptors.
Sagredo O; Ramos JA; Decio A; Mechoulam R; Fernández-Ruiz J
Eur J Neurosci; 2007 Aug; 26(4):843-51. PubMed ID: 17672854
[TBL] [Abstract][Full Text] [Related]
12. Evidence for the putative cannabinoid receptor (GPR55)-mediated inhibitory effects on intestinal contractility in mice.
Ross GR; Lichtman A; Dewey WL; Akbarali HI
Pharmacology; 2012; 90(1-2):55-65. PubMed ID: 22759743
[TBL] [Abstract][Full Text] [Related]
13. Role of pre-junctional CB1, but not CB2 , TRPV1 or GPR55 receptors in anandamide-induced inhibition of the vasodepressor sensory CGRPergic outflow in pithed rats.
Marichal-Cancino BA; Altamirano-Espinoza AH; Manrique-Maldonado G; MaassenVanDenBrink A; Villalón CM
Basic Clin Pharmacol Toxicol; 2014 Mar; 114(3):240-7. PubMed ID: 24118786
[TBL] [Abstract][Full Text] [Related]
14. The cannabinoid receptor CB1 modulates the signaling properties of the lysophosphatidylinositol receptor GPR55.
Kargl J; Balenga N; Parzmair GP; Brown AJ; Heinemann A; Waldhoer M
J Biol Chem; 2012 Dec; 287(53):44234-48. PubMed ID: 23161546
[TBL] [Abstract][Full Text] [Related]
15. The G protein-coupled receptor 55 ligand l-α-lysophosphatidylinositol exerts microglia-dependent neuroprotection after excitotoxic lesion.
Kallendrusch S; Kremzow S; Nowicki M; Grabiec U; Winkelmann R; Benz A; Kraft R; Bechmann I; Dehghani F; Koch M
Glia; 2013 Nov; 61(11):1822-31. PubMed ID: 24038453
[TBL] [Abstract][Full Text] [Related]
16. Role of Endothelium in Abnormal Cannabidiol-Induced Vasoactivity in Retinal Arterioles.
Su EN; Kelly ME; Cringle SJ; Yu DY
Invest Ophthalmol Vis Sci; 2015 Jun; 56(6):4029-37. PubMed ID: 26098470
[TBL] [Abstract][Full Text] [Related]
17. LH-21 and abnormal cannabidiol improve β-cell function in isolated human and mouse islets through GPR55-dependent and -independent signalling.
Ruz-Maldonado I; Pingitore A; Liu B; Atanes P; Huang GC; Baker D; Alonso FJ; Bermúdez-Silva FJ; Persaud SJ
Diabetes Obes Metab; 2018 Apr; 20(4):930-942. PubMed ID: 29205751
[TBL] [Abstract][Full Text] [Related]
18. Atypical cannabinoid stimulates endothelial cell migration via a Gi/Go-coupled receptor distinct from CB1, CB2 or EDG-1.
Mo FM; Offertáler L; Kunos G
Eur J Pharmacol; 2004 Apr; 489(1-2):21-7. PubMed ID: 15063151
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
